je.st
news
Galena Biopharma to Present Final GALE-401 Phase 2 Clinical Data at...
2015-11-06 19:09:55| Biotech - Topix.net
Galena Biopharma to Present Final GALE-401 Phase 2 Clinical Data at the 57th American Society of Hematology Annual Meeting and Exposition SAN RAMON, Calif., Nov. 6, 2015 -- Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the final data from the Company's GALE-401 Phase 2 proof-of-concept clinical trial will be presented at the upcoming 57th American Society of Hematology Annual Meeting and Exposition in Orlando, FL.
Tags: at
data
present
final
Category:Biotechnology and Pharmaceuticals